BBIO logo BridgeBio Pharma : BBIO

BBIO

Stock Data

$77.19

Change up

$0.93 (1.22%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

BridgeBio Pharma Inc is a pioneering biopharmaceutical company focused on developing innovative medicines for genetic diseases and cancers. With a robust pipeline, it is advancing treatments through clinical trials, including therapies for TTR amyloidosis, achondroplasia, congenital adrenal hyperplasia, autosomal dominant hypocalcemia, and limb-girdle muscular dystrophy. Founded in 2015 and based in Palo Alto, California, BridgeBio collaborates with leading institutions to transform scientific discoveries into breakthrough treatments.

All BridgeBio Pharma Articles

5 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.